Our Strategy

We are a specialty pharmaceutical company focused on commercializing products for the hospital and adjacent specialty markets. We are actively seeking to expand our portfolio of products for these markets through the acquisition of companies and products and through internal development. 

Our strategy is to:

• Focus our commercial and development efforts in the hospital and adjacent specialty markets within the U.S. pharmaceutical marketplace;
• Acquire companies, marketed or registration-stage products, and late-stage development products that fit within our focus areas; and
• Market approved generic products through our wholly-owned subsidiary, Aristos.